Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 240

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Combination pharmacotherapy for management of chronic pain: from bench to bedside

Gilron, Ian, Jensen, Troels S, Dickenson, Anthony H · 2013 · The Lancet Neurology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(13)70193-5

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 74

  1. Gaskin, 2012, The economic costs of pain in the United States, J Pain, 13, 715, 10.1016/j.jpain.2012.03.009 · DOI · Paper page
  2. Sikandar, 2013, No need for translation when the same language is spoken, Br J Anaesth, 111, 3, 10.1093/bja/aet210 · DOI
  3. Chaparro, 2012, Combination pharmacotherapy for the treatment of neuropathic pain in adults, Cochrane Database Syst Rev, 7
  4. Gilron, 2005, Combination pharmacotherapy for neuropathic pain: current evidence and future directions, Expert Rev Neurother, 5, 823, 10.1586/14737175.5.6.823 · DOI
  5. Juniper, 2002, Impact of inhaled salmeterol/fluticasone propionate combination product versus budesonide on the health-related quality of life of patients with asthma, Am J Respir Med, 1, 435, 10.1007/BF03257170 · DOI
  6. Lilenbaum, 1998, Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival, Cancer, 82, 116, 10.1002/(SICI)1097-0142(19980101)82:1<116::AID-CNCR14>3.0.CO;2-5 · doi:10.1002/(sici)1097-0142(19980101)82:1<116::aid-cncr14>3.0.co;2-5
  7. Berger, 2012, Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study, BMC Neurol, 12, 8, 10.1186/1471-2377-12-8 · DOI
  8. Finnerup, 2010, The evidence for pharmacological treatment of neuropathic pain, Pain, 150, 573, 10.1016/j.pain.2010.06.019 · DOI · Paper page
  9. Basbaum, 2009, Cellular and molecular mechanisms of pain, Cell, 139, 267, 10.1016/j.cell.2009.09.028 · DOI · Paper page
  10. Tallarida, 1992, Statistical analysis of drug combinations for synergism, Pain, 49, 93, 10.1016/0304-3959(92)90193-F · DOI · Paper page
  11. Dickenson, 1993, Combination therapy in analgesia; seeking synergy, Curr Opin Anaesthesiol, 6, 861, 10.1097/00001503-199310000-00020 · doi:10.1097/00001503-199310000-00020
  12. Straube, 2011, Combined analgesics in (headache) pain therapy: shotgun approach or precise multi-target therapeutics?, BMC Neurol, 11, 43, 10.1186/1471-2377-11-43 · DOI
  13. Saab, 2008, Alarm or curse? The pain of neuroinflammation, Brain Res Rev, 58, 226, 10.1016/j.brainresrev.2008.04.002 · DOI
  14. Schweinhardt, 2010, Pain imaging in health and disease: how far have we come, J Clin Invest, 120, 3788, 10.1172/JCI43498 · DOI · Paper page
  15. Jensen, 2003, Translation of symptoms and signs into mechanisms in neuropathic pain, Pain, 102, 1, 10.1016/s0304-3959(03)00006-x · DOI · Paper page
  16. Jänig, 1996, Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma, Prog Brain Res, 113, 161, 10.1016/S0079-6123(08)61087-0 · DOI · Paper page
  17. Jensen, 2011, A new definition of neuropathic pain, Pain, 152, 2204, 10.1016/j.pain.2011.06.017 · DOI · Paper page
  18. Maier, 2010, Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes, Pain, 150, 439, 10.1016/j.pain.2010.05.002 · DOI · Paper page
  19. Graven-Nielsen, 2010, Assessment of mechanisms in localized and widespread musculoskeletal pain, Nat Rev Rheumatol, 6, 599, 10.1038/nrrheum.2010.107 · DOI · Paper page
  20. Leavitt, 1986, Characteristics and frequency of malingering among patients with low back pain, Pain, 25, 357, 10.1016/0304-3959(86)90239-3 · doi:10.1016/0304-3959(86)90239-3
  21. De Felice, 2011, Engagement of descending inhibition from the rostral ventromedial medulla protects against chronic neuropathic pain, Pain, 152, 2701, 10.1016/j.pain.2011.06.008 · DOI · Paper page
  22. Porreca, 2001, Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor, J Neurosci, 21, 5281, 10.1523/JNEUROSCI.21-14-05281.2001 · DOI · Paper page
  23. Suzuki, 2004, Bad news from the brain: descending 5-HT pathways that control spinal pain processing, Trends Pharmacol Sci, 25, 613, 10.1016/j.tips.2004.10.002 · DOI · Paper page
  24. Bennett, 2007, Using screening tools to identify neuropathic pain, Pain, 127, 199, 10.1016/j.pain.2006.10.034 · DOI · Paper page
  25. Turk, 2010, Assessment and treatment of psychosocial comorbidities in patients with neuropathic pain, Mayo Clin Proc, 85, S42, 10.4065/mcp.2009.0648 · DOI · Paper page
  26. Hochberg, 2012, American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee, Arthritis Care Res (Hoboken), 64, 465, 10.1002/acr.21596 · DOI · Paper page
  27. Koes, 2010, An updated overview of clinical guidelines for the management of non-specific low back pain in primary care, Eur Spine J, 19, 2075, 10.1007/s00586-010-1502-y · DOI · Paper page
  28. Finnerup, 2006, Mechanisms of disease: mechanism-based classification of neuropathic pain—a critical analysis, Nat Clin Pract Neurol, 2, 107, 10.1038/ncpneuro0118 · DOI
  29. Hanna, 2008, Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients, Eur J Pain, 12, 804, 10.1016/j.ejpain.2007.12.010 · DOI · Paper page
  30. Khoromi, 2007, Morphine, nortriptyline and their combination vs placebo in patients with chronic lumbar root pain, Pain, 130, 66, 10.1016/j.pain.2006.10.029 · DOI · Paper page
  31. Eichenberger, 2008, Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds, Anesth Analg, 106, 1265, 10.1213/ane.0b013e3181685014 · DOI · Paper page
  32. Graff-Radford, 2000, Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia, Clin J Pain, 16, 188, 10.1097/00002508-200009000-00002 · DOI
  33. Dib-Hajj, 2013, The Na(V)1.7 sodium channel: from molecule to man, Nat Rev Neurosci, 14, 49, 10.1038/nrn3404 · DOI · Paper page
  34. Faber, 2012, Gain-of-function Nav1.8 mutations in painful neuropathy, Proc Natl Acad Sci USA, 109, 19444, 10.1073/pnas.1216080109 · DOI · Paper page
  35. Dib-Hajj, 2010, Sodium channels in normal and pathological pain, Annu Rev Neurosci, 33, 325, 10.1146/annurev-neuro-060909-153234 · DOI · Paper page
  36. Fertleman, 2006, SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes, Neuron, 52, 767, 10.1016/j.neuron.2006.10.006 · DOI · Paper page
  37. Bauer, 2009, The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin, J Neurosci, 29, 4076, 10.1523/JNEUROSCI.0356-09.2009 · DOI · Paper page
  38. D'Mello, 2008, Spinal cord mechanisms of pain, Br J Anaesth, 101, 8, 10.1093/bja/aen088 · DOI · Paper page
  39. Bannister, 2009, Preclinical and early clinical investigations related to monoaminergic pain modulation, Neurotherapeutics, 6, 703, 10.1016/j.nurt.2009.07.009 · DOI · Paper page
  40. Ossipov, 2010, Central modulation of pain, J Clin Invest, 120, 3779, 10.1172/JCI43766 · DOI · Paper page
  41. Bee, 2008, Descending facilitation from the brainstem determines behavioural and neuronal hypersensitivity following nerve injury and efficacy of pregabalin, Pain, 140, 209, 10.1016/j.pain.2008.08.008 · DOI
  42. Yamamoto, 1992, Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy, Neurosci Lett, 135, 67, 10.1016/0304-3940(92)90137-V · DOI
  43. Gilron, 2003, Gabapentin blocks and reverses antinociceptive morphine tolerance in the rat paw-pressure and tail-flick tests, Anesthesiology, 98, 1288, 10.1097/00000542-200305000-00037 · DOI
  44. Matthews, 2002, A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy, Anesthesiology, 96, 633, 10.1097/00000542-200203000-00020 · doi:10.1097/00000542-200203000-00020
  45. Christoph, 2011, Synergistic antihypersensitive effects of pregabalin and tapentadol in a rat model of neuropathic pain, Eur J Pharmacol, 666, 72, 10.1016/j.ejphar.2011.05.029 · doi:10.1016/j.ejphar.2011.05.029
  46. Virani, 1997, Drug interactions in human neuropathic pain pharmacotherapy, Pain, 73, 3, 10.1016/S0304-3959(97)00041-9 · DOI
  47. Haanpää, 2010, Treatment considerations for patients with neuropathic pain and other medical comorbidities, Mayo Clin Proc, 85, S15, 10.4065/mcp.2009.0645 · DOI
  48. Elia, 2005, Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials, Anesthesiology, 103, 1296, 10.1097/00000542-200512000-00025 · DOI · Paper page
  49. Gilron, 2005, Morphine, gabapentin, or their combination for neuropathic pain, N Engl J Med, 352, 1324, 10.1056/NEJMoa042580 · DOI · Paper page
  50. Gilron, 2009, Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial, Lancet, 374, 1252, 10.1016/S0140-6736(09)61081-3 · DOI · Paper page
  51. Gore, 2012, The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings, Spine (Phila Pa 1976), 37, E668, 10.1097/BRS.0b013e318241e5de · DOI · Paper page
  52. Gore, 2011, Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis, J Med Econ, 14, 497, 10.3111/13696998.2011.594347 · DOI
  53. Agrawal, 2009, Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study, Diabetes Res Clin Pract, 83, 371, 10.1016/j.diabres.2008.12.018 · DOI
  54. Amr, 2010, Multi-day low dose ketamine infusion as adjuvant to oral gabapentin in spinal cord injury related chronic pain: a prospective, randomized, double blind trial, Pain Physician, 13, 245, 10.36076/ppj.2010/13/245 · DOI
  55. Caraceni, 2004, Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group, J Clin Oncol, 22, 2909, 10.1200/JCO.2004.08.141 · DOI · Paper page
  56. Freeman, 2007, Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy, Curr Med Res Opin, 23, 147, 10.1185/030079906X162674 · DOI
  57. Gomez-Perez, 1985, Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy: a double-blind cross-over study, Pain, 23, 395, 10.1016/0304-3959(85)90010-7 · DOI · Paper page
  58. Gomez-Perez, 1996, Nortriptyline-fluphenazine vs carbamazepine in the symptomatic treatment of diabetic neuropathy, Arch Med Res, 27, 525
  59. Lynch, 2003, A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain, Clin J Pain, 19, 323, 10.1097/00002508-200309000-00007 · DOI
  60. Lynch, 2005, Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial, Anesthesiology, 103, 140, 10.1097/00000542-200507000-00021 · DOI
  61. McCleane, 2000, Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study, Br J Clin Pharmacol, 49, 574, 10.1046/j.1365-2125.2000.00200.x · DOI · Paper page
  62. McCleane, 2003, A randomised, double blind, placebo controlled crossover study of the cholecystokinin 2 antagonist L-365,260 as an adjunct to strong opioids in chronic human neuropathic pain, Neurosci Lett, 338, 151, 10.1016/S0304-3940(02)01388-5 · DOI
  63. Mercadante, 2002, Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study, Tumori, 88, 239, 10.1177/030089160208800310 · DOI · Paper page
  64. Tonet, 2008, Evaluation of oral ketamine for the treatment of neuropathic pain, Rev Bras Med, 65, 214
  65. Zin, 2010, A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin, J Pain, 11, 462, 10.1016/j.jpain.2009.09.003 · DOI
  66. Ramiro, 2011, Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis), Cochrane Database Syst Rev, 10
  67. Buescher, 2004, Does acetaminophen and NSAID combined relieve osteoarthritis pain better than either alone?, J Fam Pract, 53, 501
  68. Romanò, 2012, Antineuropathic and antinociceptive drugs combination in patients with chronic low back pain: a systematic review, Pain Res Treat, 2012, 154781
  69. Romanò, 2009, Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain, J Orthop Traumatol, 10, 185, 10.1007/s10195-009-0077-z · DOI
  70. Fallon, 2011, A systematic review of combination step III opioid therapy in cancer pain: an EPCRC opioid guideline project, Palliat Med, 25, 597, 10.1177/0269216310392101 · doi:10.1177/0269216310392101
  71. Lauretti, 2003, Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients, Br J Cancer, 89, 2027, 10.1038/sj.bjc.6601365 · DOI
  72. Raja, 2005, Combination therapy for neuropathic pain: which drugs, which combination, which patients?, N Engl J Med, 352, 1373, 10.1056/NEJMe058039 · DOI
  73. Jyrkkä, 2009, Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study—a cross-sectional analysis, Drugs Aging, 26, 493, 10.2165/00002512-200926060-00006 · DOI · Paper page
  74. Podolsky, 2011, Combination drugs: hype, harm, and hope, N Engl J Med, 365, 488, 10.1056/NEJMp1106161 · DOI

Cited by

See all 240

Metadata

Authors
Gilron, I., Jensen, T. S., & Dickenson, A. H.
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2013-11
Volume
12
Issue
11
Pages
1084-1095
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2171872873
Cited by
240
References
11
FWCI
15.51
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
Canadian Institutes of Health Research (MSH-55041)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combination pharmacotherapy for management of chronic pain: from bench to bedside. https://app.cochat.ai/papers/10.1016/s1474-4422(13)70193-5
The paper
Gilron, I., Jensen, T. S., & Dickenson, A. H. (2013). Combination pharmacotherapy for management of chronic pain: from bench to bedside. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(13)70193-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.